Guardant Health Director Files Form 144 for Proposed Sale of 116 Shares
Guardant Health, Inc.
Subscribe to track GH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Proposed Sale: Musa Tariq (Director) filed Form 144 to sell 116 shares of Guardant Health, Inc. ($GH) valued at approximately $19,242.00 under a Rule 10b5-1 plan adopted on 12/17/2025.
Comprehensive Analysis
Guardant Health, Inc. (GH) Form 144 Filing Analysis
Overview: On October 16, 2026, Musa Tariq, a Director of Guardant Health, Inc., filed a Form 144 indicating an intention to sell 116 shares of Common Stock through broker Charles Schwab & Co., Inc.
Transaction Details:
- Proposed Sale Date: October 16, 2026
- Volume: 116 shares
- Aggregate Market Value: $19,242.00 (approx. $165.88 per share)
- Shares Outstanding: 134,196,170 shares
- Pre-set Trading Plan: The transaction is executed pursuant to a Rule 10b5-1 trading plan adopted on December 17, 2025.
- Origin of Shares: Acquired via restricted stock lapse on September 15, 2026, as part of equity compensation.
Prior Recent Sales (Past 3 Months):
- 07/16/2026: 116 shares for gross proceeds of $18,941.00
- 08/17/2026: 116 shares for gross proceeds of $18,148.00
- 09/16/2026: 116 shares for gross proceeds of $20,300.00
Market Impact & Significance: Trading significance is rated as Low. The transaction size represents an insignificant fraction of total outstanding shares (<0.001%) and reflects routine, scheduled monthly sales under a pre-established 10b5-1 trading plan.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.